The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Imaging: Lung cysts or bullae (see also XVI ah/bf)
Publications
New targeted molecular therapies for cancer: radiological response in intrathoracic malignancies and cardiopulmonary toxicity: what the radiologist needs to know.
Cancer imaging : the official publication of the International Cancer Imaging Society 2014 Jul 23;14;26 — 2014 Jul 23 — 26
Tumoral cavitation in patients with non-small-cell lung cancer treated with antiangiogenic therapy using bevacizumab.
Cancer imaging : the official publication of the International Cancer Imaging Society 2012 Jun 29;12;225-35 — 2012 Jun 29 — 225-35
Antiangiogenesis induced tumor cavitation in lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2009 Dec;4;1573-5 — 2009 Dec — 1573-5